Clover Health Investments is trading lower Tuesday afternoon after the Trump administration proposed flat MA payment rates for 2027.

What Happened? Shares of health insurance company Clover Health (NASDAQ:CLOV) jumped 2.5% in the afternoon session after ...

The MarketWatch News Department was not involved in the creation of this content. Company underscores differentiated business model; reiterates confidence in its ability to drive above-market ...

Clover Health, an insurance startup backed by Google’s parent company Alphabet, diminished its losses from $35 million in 2016 to $22 million in 2017, according to Bloomberg. Clover initially only ...

Shares of health insurance company Clover Health (NASDAQ:CLOV) jumped 10% in the afternoon session after the company ...

Clover Health, an insurtech startup targeting the Medicare Advantage market, will close a new round of funding within the next couple of weeks led by Greenoaks Capital, Clover CEO Vivek Garipalli ...

Shares of Clover Health Investments plummeted more than 20 percent at one point Wednesday afternoon, a day after the Franklin-based health insurance company reported second-quarter results. At ...

Clover Health Investments is now a contrarian buy, with the market underestimating its path to profitability in 2026. See why I rate the CLOV stock a Buy.

Fourth Quarter and Full Year 2025 Conference Webcast Details: What : Clover Health’s Fourth Quarter and Full Year 2025 Earnings Conference Call A live and archived webcast of the conference call will ...

The Department of Health and Human Services and Centers for Medicare & Medicaid Services were hit with an administrative lawsuit on Nov. 7 in Georgia Southern District Court over their Medicare ...